Aetion
Shannon Reynolds has held significant positions in the field of epidemiology and research. In their current role at Aetion as Vice President of Science, they lead a team of researchers focused on real-world healthcare research projects. With previous experience at Humana and United BioSource Corp., Shannon has a strong background in overseeing collaboration between healthcare organizations and pharmaceutical clients. Their work also includes surveillance and investigation of notifiable diseases, as well as conducting epidemiologic research projects. Shannon's educational background includes a Master's Degree in Epidemiology from Emory University Rollins School of Public Health and a BS in Human Physiology from Boston University.
This person is not in any teams
This person is not in any offices
Aetion
9 followers
Aetion is a health care technology company that delivers real-world evidence for life sciences, payers, providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on treatments, costs, and outcomes. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era.